Zacks: Analysts Expect Tyme Technologies Inc (TYME) Will Announce Earnings of -$0.08 Per Share
Wall Street analysts predict that Tyme Technologies Inc (NASDAQ:TYME) will post ($0.08) earnings per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Tyme Technologies’ earnings. Tyme Technologies reported earnings per share of ($0.06) during the same quarter last year, which would suggest a negative year over year growth rate of 33.3%. The company is scheduled to report its next earnings report on Wednesday, February 6th.
On average, analysts expect that Tyme Technologies will report full year earnings of ($0.30) per share for the current year. For the next fiscal year, analysts expect that the business will report earnings of ($0.37) per share. Zacks’ earnings per share averages are a mean average based on a survey of research firms that cover Tyme Technologies.
Tyme Technologies (NASDAQ:TYME) last announced its quarterly earnings data on Monday, November 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.01.
Institutional investors and hedge funds have recently bought and sold shares of the business. Rhumbline Advisers acquired a new stake in Tyme Technologies during the second quarter worth $110,000. Renaissance Technologies LLC acquired a new stake in Tyme Technologies during the third quarter worth $100,000. Schwab Charles Investment Management Inc. acquired a new stake in Tyme Technologies during the second quarter worth $248,000. Bank of New York Mellon Corp acquired a new stake in Tyme Technologies during the second quarter worth $267,000. Finally, Wells Fargo & Company MN boosted its stake in Tyme Technologies by 149.1% during the third quarter. Wells Fargo & Company MN now owns 266,026 shares of the company’s stock worth $739,000 after buying an additional 159,251 shares in the last quarter. Hedge funds and other institutional investors own 11.28% of the company’s stock.
Shares of Tyme Technologies stock traded down $0.09 during midday trading on Friday, hitting $2.61. The company had a trading volume of 1,301,050 shares, compared to its average volume of 1,106,461. The company has a market cap of $303.38 million, a price-to-earnings ratio of -12.43 and a beta of 0.80. Tyme Technologies has a 1-year low of $1.93 and a 1-year high of $7.00.
Tyme Technologies Company Profile
Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.
Recommended Story: Stock Symbol
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.